BCL10 in malignant lymphomas - an evaluation using fluorescencein situ hybridization
- 19 November 2001
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 196 (1) , 59-66
- https://doi.org/10.1002/path.1015
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- BCL10 deletions in haematological malignancies: a cloning artefact?British Journal of Haematology, 2000
- Infrequent BCL10 Mutations in B‐Cell Non‐Hodgkin's LymphomasJapanese Journal of Cancer Research, 1999
- BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomasBritish Journal of Cancer, 1999
- Lack of Bcl10 mutations in testicular germ cell tumours and derived cell linesBritish Journal of Cancer, 1999
- Bcl10 is not a target for frequent mutation in human carcinomasBritish Journal of Cancer, 1999
- Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)Nature Genetics, 1999
- CIPER, a Novel NF κB-activating Protein Containing a Caspase Recruitment Domain with Homology to Herpesvirus-2 Protein E10Published by Elsevier ,1999
- Cytogenetics and the surgeon: an invaluable tool in diagnosis, prognosis and counselling of patients with solid tumoursBritish Journal of Surgery, 1998
- BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: A molecular and cytogenetic studyGenes, Chromosomes and Cancer, 1997
- Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissueCancer Genetics and Cytogenetics, 1992